GSK

Últimas notícias

Manchetes no idioma original da fonte.

• GSK | 10/2/26 (abre em uma nova aba)

  ktnv.com · 2 de out. de 2026

• Voting rights update pressures GSK stock near GBX1,847 resistance (abre em uma nova aba)

  Traders Union · 2 de out. de 2026

• The Technical Signals Behind (GSK) That Institutions Follow (abre em uma nova aba)

  Stock Traders Daily · 1 de out. de 2026

• Kristian Jensen: Begining a New Chapter at GSK After Novartis Journey (abre em uma nova aba)

  Oncodaily · 1 de out. de 2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (abre em uma nova aba)

  Stock Titan · 1 de out. de 2026

• GSK adds liver candidate from Wave RNA partnership (abre em uma nova aba)

  European Biotechnology Magazine · 1 de out. de 2026

• What's behind GSK's latest 1.8% stock pullback? (abre em uma nova aba)

  Traders Union · 1 de out. de 2026

• GSK Updates Market on Total Voting Rights and Share Capital (abre em uma nova aba)

  TipRanks · 1 de out. de 2026

• 
  Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks (abre em uma nova aba)

  Simply Wall St. · 1 de out. de 2026

• GSK plc : JP Morgan reiterates its Sell rating (abre em uma nova aba)

  marketscreener.com · 1 de out. de 2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (abre em uma nova aba)

  BioBuzz · 1 de out. de 2026

• Why Did Haleon (LSE:HLN) Draw Attention As GSK Completed Its Exit This Week? (abre em uma nova aba)

  kalkinemedia.com · 1 de out. de 2026

• How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? (abre em uma nova aba)

  kalkinemedia.com · 1 de out. de 2026

• Wave lands USD 12m as GSK advances SpiNA siRNA program (abre em uma nova aba)

  AllSci · 1 de out. de 2026

• Why is GSK stock down today? Selloff intensifies, key levels to watch (abre em uma nova aba)

  Traders Union · 1 de out. de 2026

• GSK 6-K & SEC Filings (abre em uma nova aba)

  Yahoo Finance · 1 de out. de 2026

• GSK (LSE:GSK) Expands TB Research as Gates Funding Continues (abre em uma nova aba)

  kalkinemedia.com · 1 de out. de 2026

• GSK Pharma stock enters a results blackout before Q2 FY27 (abre em uma nova aba)

  ad-hoc-news.de · 1 de out. de 2026

• Wave Life announces GSK’s selection of siRNA program to transition to GSK (abre em uma nova aba)

  TipRanks · 1 de out. de 2026

• GSK (LSE:GSK) Gets Extended Gates Funding For Tuberculosis Drug Research (abre em uma nova aba)

  Simply Wall Street · 1 de out. de 2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (abre em uma nova aba)

  Fierce Biotech · 30 de set. de 2026

• Does GSK (LSE:GSK) Have Fresh Momentum As London Pharma Gets A Lift From Cancer Dealmaking With FTSE 100 In Focus? (abre em uma nova aba)

  Kalkine Media · 30 de set. de 2026

• GSK selects Wave Life Sciences hepatology candidate By Investing.com (abre em uma nova aba)

  Investing.com UK · 30 de set. de 2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (abre em uma nova aba)

  Yahoo Finance · 30 de set. de 2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (abre em uma nova aba)

  Yahoo Finance · 30 de set. de 2026

• Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies (abre em uma nova aba)

  30 de set. de 2026

• Can GSK shares outperform FTSE 100 index over the long run? (abre em uma nova aba)

  Interactive Investor · 30 de set. de 2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (abre em uma nova aba)

  FirstWord Pharma · 29 de set. de 2026

• Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push (abre em uma nova aba)

  This is Money · 29 de set. de 2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (abre em uma nova aba)

  Proactive financial news · 29 de set. de 2026